-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Lisata Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Lisata Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$5.52M, a 19.7% increase year-over-year.
- Lisata Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$24.1M, a 58.4% increase year-over-year.
- Lisata Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$25.7M, a 55.4% increase from 2022.
- Lisata Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$57.6M, a 98.3% decline from 2021.
- Lisata Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$29.1M, a 51.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)